Prestige Consumer Healthcare (PBH) Set to Announce Earnings on Thursday

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) is set to announce its earnings results before the market opens on Thursday, November 7th. Analysts expect the company to announce earnings of $1.09 per share for the quarter. Prestige Consumer Healthcare has set its FY25 guidance at $4.40-4.46 EPS and its FY 2025 guidance at 4.400-4.460 EPS.Investors interested in registering for the company's conference call can do so using this link.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.04. The firm had revenue of $267.10 million for the quarter, compared to analysts' expectations of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company's revenue for the quarter was down 4.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.06 earnings per share. On average, analysts expect Prestige Consumer Healthcare to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Prestige Consumer Healthcare Price Performance

Shares of Prestige Consumer Healthcare stock traded up $0.19 on Thursday, hitting $73.75. 237,280 shares of the company traded hands, compared to its average volume of 245,685. The stock has a market capitalization of $3.66 billion, a P/E ratio of 17.99, a price-to-earnings-growth ratio of 2.06 and a beta of 0.47. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. Prestige Consumer Healthcare has a 52 week low of $56.61 and a 52 week high of $75.80. The business has a 50-day simple moving average of $72.06 and a 200 day simple moving average of $69.49.

Analysts Set New Price Targets

A number of research analysts recently weighed in on PBH shares. DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a "buy" rating in a report on Wednesday, August 28th. Jefferies Financial Group reissued a "hold" rating and issued a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $94.20.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.